https://www.selleckchem.com/pr....oducts/l-mimosine.ht
001) at 12 weeks. Short-term success was achieved in 51.5% and 72.2% of eyes at 5 and 12 weeks, respectively. SLT was most effective in OHTN subgroup and those with higher baseline IOP (both P 0.001). Side effects were an infrequent occurrence, minor and transient. The short-term success of SLT in Omani eyes was clinically relevant and comparable to the gradual pattern seen in patients of Indian ancestry. It is a safe therapeutic option in selective Omani eyes. The short-term success of SLT in Omani eyes was clinically relevant a